Physician Photo

Christopher John (Chris) Cutie, MD

Assistant in Urology

Instructor in Surgery

  • Phone: 617-643-7983
Department of Urology


  • Cancer Center
  • Genitourinary Oncology
Clinical Interests
Prostate, kidney, bladder
Testicular, penile and genito-urinary cancers
Laparoscopic surgery, Brachytherapy (radioactive seeds),
Orthotopic neobladder, bladder reconstruction
Boston: Massachusetts General Hospital
Medical Education
MD, Yale University School of Medicine
Residency, Massachusetts General Hospital
Board Certifications
Urology, American Board of Urology
Foreign Languages
Patient Age Group
Accepting New Patients


Dr. Cutie graduated from the University of Pennsylvania with honors, where he majored in anthropology. His thesis project was to study the evolution of concealed ovulation in primates. He then attended medical school at Yale University, where he received the Marguerite Rush Lerner Humanities in Medicine Award. He completed his internship and residency training at Harvard Medical School. 

Dr. Cutie spent two years in General Surgery training at the Massachusetts General Hospital. He then completed four years of training in Urology at the Massachusetts General Hospital. This program included training at the Children's Hospital of Boston. He then pursued an oncology fellowship at the Massachusetts General Hospital, where he studied prognostic genomic signatures and their utility in the prediction of prostate cancer recurrence in men who have undergone radical prostatectomy.

Dr. Cutie received a Master's Degree in Business Administration from the Harvard Business School. He is the co-founder of two medical device companies.


Dr. Cutie's current area of oncology research studies the utility of geniomic signatures in the prediction of prostate and bladder cancer recurrence. This involves collaborations between the MGH Departments of Pathology and Urology.

Dr. Cutie is also keenly interested in medical devices and diagnostic tools. He is the co-founder of a medical diagnostics start-up company, and currently has a catheter-based device under develoment in collaboration with the Massachusetts General Hospital Innovation Support Group. 


1. 2009 Daha AK, Osbourne AL, CutieCJ, Gervais DA, Dahl DM, Feldman AS. Choice of Nephron Sparing Techniquecorrelates with change in GFR: Percutaneous Radiofrequency Ablation (RFA) vs.Open and Laparoscopic Partial Nephrectomy. NE-AUA (Abstract) 2009.

2. 2009 Osbourne AL, Daha AK, Cutie CJ, Dahl DM, Feldman, AS. Comparison of Laparoscopic and Open PartialNephrectomy. A retrospective review at the Massachusetts General Hospital.NE-AUA (Abstract) 2009. 

3. 2009 Cutie CJ, Dahl DM. BCGosis. 5-Minute Urology Consult. Gomella L(eds); 2009.

4. 2009 Cutie CJ, Dahl DM. Cushin?sDisease/Syndrome. 5-Minute UrologyConsult. Gomella L (eds); 2009.

5. 2009 Cutie CJ, Dahl DM. RenalCysts. 5-Minute Urology Consult.Gomella L (eds); 2009. 

6. 2008 CutieCJ, McDougal WS. Obstructive Uropathy. Therapyin Nephrology and Hypertension. Brady HR, Wilcox CS (eds); 2008. 

7. 2008 Ongaro T, Cutie CJ. Vasectomy. UpToDate2008 (e-publication).

Mass General Urology Associates
15 Parkman St
Boston, MA 02114-3117

Phone: 617-643-7983
Fax: 617-726-6131